Diagnostic Performance of Mac-2-Binding Protein Glycosylation Isomer (M2BPGi), compared to Transient Elastography to Assess Liver Stiffness in Treatment Naïve Chronic Hepatitis C Patients

Background: Liver fibrosis is an essential factor in the management of Hepatitis C virus infection. Its assessment is crucial in decision-making regarding the therapeutic decisions, and the patients’ follow up. However, the established liver measurement methods have several limitations. Therefore, t...

Full description

Saved in:
Bibliographic Details
Main Authors: Andri Sanityoso Sulaiman, Irsan Hasan, Cosmas Rinaldi A Lesmana, Juferdy Kurniawan, Chyntia Olivia Maurine Jasirwan, Saut Nababan, Kemal Fariz Kalista, Rachmadianti Sukma Hanifa, Desti Rachmani, Rino Alvani Gani
Format: Article
Language:English
Published: Interna Publishing 2023-01-01
Series:Acta Medica Indonesiana
Subjects:
Online Access:http://www.actamedindones.org/index.php/ijim/article/view/2168
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849320692162494464
author Andri Sanityoso Sulaiman
Irsan Hasan
Cosmas Rinaldi A Lesmana
Juferdy Kurniawan
Chyntia Olivia Maurine Jasirwan
Saut Nababan
Kemal Fariz Kalista
Rachmadianti Sukma Hanifa
Desti Rachmani
Rino Alvani Gani
author_facet Andri Sanityoso Sulaiman
Irsan Hasan
Cosmas Rinaldi A Lesmana
Juferdy Kurniawan
Chyntia Olivia Maurine Jasirwan
Saut Nababan
Kemal Fariz Kalista
Rachmadianti Sukma Hanifa
Desti Rachmani
Rino Alvani Gani
author_sort Andri Sanityoso Sulaiman
collection DOAJ
description Background: Liver fibrosis is an essential factor in the management of Hepatitis C virus infection. Its assessment is crucial in decision-making regarding the therapeutic decisions, and the patients’ follow up. However, the established liver measurement methods have several limitations. Therefore, this study aims to assess the role of Mac-2-Binding Protein Glycosylation Isomer (M2BPGi) as a novel biomarker to measure liver stiffness in treatment naïve Chronic Hepatitis C Indonesian patients. Methods: This study used a cross-sectional design to determine the correlation between serum M2BPGi and the degree of liver stiffness, Transient Elastrography, and differences in serum M2BPGi levels in chronic hepatitis C patients. Serum M2BPGi level and Transient Elastography results were evaluated in 56 Chronic Hepatitis C patients and 48 healthy controls. Pearson correlation analysis was conducted to find the correlation between the level of M2BPGi and Transient Elastography result. ROC analysis was conducted to find the optimum cut-off to assess fibrosis’s degree among Chronic Hepatitis C Patients. Results: The level of serum M2BPGi and Transient Elastography result was strongly correlated with the median level of serum M2BPGi. It was also significantly higher among Chronic Hepatitis C Patients than among healthy controls (r: 0.708, p<0.001; 0.590 COI vs. 4.130 COI, p<0.001). Among the Chronic Hepatitis C patients, the median serum of M2BPGi increased according to the degree of liver fibrosis: 1.500 COI (F0-F1), 2.985 COI (F2-F3) and 8.785 COI (≥F4). The optimum cut-off value for diagnosing significant fibrosis (F2-F3) was 1.820 COI (AUC: 90.8%) and for diagnosing cirrhosis (≥F4) was 3.770 COI (AUC: 89.3%). Conclusion: Serum M2BPGi was a reliable diagnostic tool for identifying liver fibrosis in Indonesian patients with Chronic Hepatitis C.
format Article
id doaj-art-e83d32bd97d54de283923dfe2cf3e3f0
institution Kabale University
issn 0125-9326
2338-2732
language English
publishDate 2023-01-01
publisher Interna Publishing
record_format Article
series Acta Medica Indonesiana
spelling doaj-art-e83d32bd97d54de283923dfe2cf3e3f02025-08-20T03:50:00ZengInterna PublishingActa Medica Indonesiana0125-93262338-27322023-01-01544Diagnostic Performance of Mac-2-Binding Protein Glycosylation Isomer (M2BPGi), compared to Transient Elastography to Assess Liver Stiffness in Treatment Naïve Chronic Hepatitis C PatientsAndri Sanityoso Sulaiman0Irsan Hasan1Cosmas Rinaldi A Lesmana2Juferdy Kurniawan3Chyntia Olivia Maurine Jasirwan4Saut Nababan5Kemal Fariz Kalista6Rachmadianti Sukma Hanifa7Desti Rachmani8Rino Alvani Gani9Division of Hepatobiliary, Department of Internal Medicine, faculty of Medicine Universitas Indonesia - Dr. Cipto Mangunkusumo General Hospital, Jakarta, Indonesia.Division of Hepatobiliary, Department of Internal Medicine, faculty of Medicine Universitas Indonesia - Dr. Cipto Mangunkusumo General Hospital, Jakarta, Indonesia.Division of Hepatobiliary, Department of Internal Medicine, faculty of Medicine Universitas Indonesia - Dr. Cipto Mangunkusumo General Hospital, Jakarta, Indonesia.Division of Hepatobiliary, Department of Internal Medicine, faculty of Medicine Universitas Indonesia - Dr. Cipto Mangunkusumo General Hospital, Jakarta, Indonesia.Division of Hepatobiliary, Department of Internal Medicine, faculty of Medicine Universitas Indonesia - Dr. Cipto Mangunkusumo General Hospital, Jakarta, Indonesia.Division of Hepatobiliary, Department of Internal Medicine, faculty of Medicine Universitas Indonesia - Dr. Cipto Mangunkusumo General Hospital, Jakarta, Indonesia.Division of Hepatobiliary, Department of Internal Medicine, faculty of Medicine Universitas Indonesia - Dr. Cipto Mangunkusumo General Hospital, Jakarta, Indonesia.Division of Hepatobiliary, Department of Internal Medicine, faculty of Medicine Universitas Indonesia - Dr. Cipto Mangunkusumo General Hospital, Jakarta, Indonesia.Division of Hepatobiliary, Department of Internal Medicine, faculty of Medicine Universitas Indonesia - Dr. Cipto Mangunkusumo General Hospital, Jakarta, Indonesia.Division of Hepatobiliary, Department of Internal Medicine, faculty of Medicine Universitas Indonesia - Dr. Cipto Mangunkusumo General Hospital, Jakarta, Indonesia.Background: Liver fibrosis is an essential factor in the management of Hepatitis C virus infection. Its assessment is crucial in decision-making regarding the therapeutic decisions, and the patients’ follow up. However, the established liver measurement methods have several limitations. Therefore, this study aims to assess the role of Mac-2-Binding Protein Glycosylation Isomer (M2BPGi) as a novel biomarker to measure liver stiffness in treatment naïve Chronic Hepatitis C Indonesian patients. Methods: This study used a cross-sectional design to determine the correlation between serum M2BPGi and the degree of liver stiffness, Transient Elastrography, and differences in serum M2BPGi levels in chronic hepatitis C patients. Serum M2BPGi level and Transient Elastography results were evaluated in 56 Chronic Hepatitis C patients and 48 healthy controls. Pearson correlation analysis was conducted to find the correlation between the level of M2BPGi and Transient Elastography result. ROC analysis was conducted to find the optimum cut-off to assess fibrosis’s degree among Chronic Hepatitis C Patients. Results: The level of serum M2BPGi and Transient Elastography result was strongly correlated with the median level of serum M2BPGi. It was also significantly higher among Chronic Hepatitis C Patients than among healthy controls (r: 0.708, p<0.001; 0.590 COI vs. 4.130 COI, p<0.001). Among the Chronic Hepatitis C patients, the median serum of M2BPGi increased according to the degree of liver fibrosis: 1.500 COI (F0-F1), 2.985 COI (F2-F3) and 8.785 COI (≥F4). The optimum cut-off value for diagnosing significant fibrosis (F2-F3) was 1.820 COI (AUC: 90.8%) and for diagnosing cirrhosis (≥F4) was 3.770 COI (AUC: 89.3%). Conclusion: Serum M2BPGi was a reliable diagnostic tool for identifying liver fibrosis in Indonesian patients with Chronic Hepatitis C. http://www.actamedindones.org/index.php/ijim/article/view/2168Chronic Hepatitis CMac-2-Binding Protein Glycosylation IsomerTransient Elastography
spellingShingle Andri Sanityoso Sulaiman
Irsan Hasan
Cosmas Rinaldi A Lesmana
Juferdy Kurniawan
Chyntia Olivia Maurine Jasirwan
Saut Nababan
Kemal Fariz Kalista
Rachmadianti Sukma Hanifa
Desti Rachmani
Rino Alvani Gani
Diagnostic Performance of Mac-2-Binding Protein Glycosylation Isomer (M2BPGi), compared to Transient Elastography to Assess Liver Stiffness in Treatment Naïve Chronic Hepatitis C Patients
Acta Medica Indonesiana
Chronic Hepatitis C
Mac-2-Binding Protein Glycosylation Isomer
Transient Elastography
title Diagnostic Performance of Mac-2-Binding Protein Glycosylation Isomer (M2BPGi), compared to Transient Elastography to Assess Liver Stiffness in Treatment Naïve Chronic Hepatitis C Patients
title_full Diagnostic Performance of Mac-2-Binding Protein Glycosylation Isomer (M2BPGi), compared to Transient Elastography to Assess Liver Stiffness in Treatment Naïve Chronic Hepatitis C Patients
title_fullStr Diagnostic Performance of Mac-2-Binding Protein Glycosylation Isomer (M2BPGi), compared to Transient Elastography to Assess Liver Stiffness in Treatment Naïve Chronic Hepatitis C Patients
title_full_unstemmed Diagnostic Performance of Mac-2-Binding Protein Glycosylation Isomer (M2BPGi), compared to Transient Elastography to Assess Liver Stiffness in Treatment Naïve Chronic Hepatitis C Patients
title_short Diagnostic Performance of Mac-2-Binding Protein Glycosylation Isomer (M2BPGi), compared to Transient Elastography to Assess Liver Stiffness in Treatment Naïve Chronic Hepatitis C Patients
title_sort diagnostic performance of mac 2 binding protein glycosylation isomer m2bpgi compared to transient elastography to assess liver stiffness in treatment naive chronic hepatitis c patients
topic Chronic Hepatitis C
Mac-2-Binding Protein Glycosylation Isomer
Transient Elastography
url http://www.actamedindones.org/index.php/ijim/article/view/2168
work_keys_str_mv AT andrisanityososulaiman diagnosticperformanceofmac2bindingproteinglycosylationisomerm2bpgicomparedtotransientelastographytoassessliverstiffnessintreatmentnaivechronichepatitiscpatients
AT irsanhasan diagnosticperformanceofmac2bindingproteinglycosylationisomerm2bpgicomparedtotransientelastographytoassessliverstiffnessintreatmentnaivechronichepatitiscpatients
AT cosmasrinaldialesmana diagnosticperformanceofmac2bindingproteinglycosylationisomerm2bpgicomparedtotransientelastographytoassessliverstiffnessintreatmentnaivechronichepatitiscpatients
AT juferdykurniawan diagnosticperformanceofmac2bindingproteinglycosylationisomerm2bpgicomparedtotransientelastographytoassessliverstiffnessintreatmentnaivechronichepatitiscpatients
AT chyntiaoliviamaurinejasirwan diagnosticperformanceofmac2bindingproteinglycosylationisomerm2bpgicomparedtotransientelastographytoassessliverstiffnessintreatmentnaivechronichepatitiscpatients
AT sautnababan diagnosticperformanceofmac2bindingproteinglycosylationisomerm2bpgicomparedtotransientelastographytoassessliverstiffnessintreatmentnaivechronichepatitiscpatients
AT kemalfarizkalista diagnosticperformanceofmac2bindingproteinglycosylationisomerm2bpgicomparedtotransientelastographytoassessliverstiffnessintreatmentnaivechronichepatitiscpatients
AT rachmadiantisukmahanifa diagnosticperformanceofmac2bindingproteinglycosylationisomerm2bpgicomparedtotransientelastographytoassessliverstiffnessintreatmentnaivechronichepatitiscpatients
AT destirachmani diagnosticperformanceofmac2bindingproteinglycosylationisomerm2bpgicomparedtotransientelastographytoassessliverstiffnessintreatmentnaivechronichepatitiscpatients
AT rinoalvanigani diagnosticperformanceofmac2bindingproteinglycosylationisomerm2bpgicomparedtotransientelastographytoassessliverstiffnessintreatmentnaivechronichepatitiscpatients